Browse > Article
http://dx.doi.org/10.4047/jkap.2010.48.3.202

Effect of rhPMP-2 coated implants on alveolar ridge augmentation in dogs  

Park, Chan-Kyung (Department of Advanced Prosthodontics, Graduate School of Clinical Dentistry, Institute of Clinical Dental Research, Korea University)
Kim, Jong-Eun (Department of Advanced Prosthodontics, Graduate School of Clinical Dentistry, Institute of Clinical Dental Research, Korea University)
Shin, Ju-Hee (Department of Advanced Prosthodontics, Graduate School of Clinical Dentistry, Institute of Clinical Dental Research, Korea University)
Ryu, Jae-Jun (Department of Advanced Prosthodontics, Graduate School of Clinical Dentistry, Institute of Clinical Dental Research, Korea University)
Huh, Jung-Bo (Department of Advanced Prosthodontics, Graduate School of Clinical Dentistry, Institute of Clinical Dental Research, Korea University)
Shin, Sang-Wan (Department of Advanced Prosthodontics, Graduate School of Clinical Dentistry, Institute of Clinical Dental Research, Korea University)
Publication Information
The Journal of Korean Academy of Prosthodontics / v.48, no.3, 2010 , pp. 202-208 More about this Journal
Abstract
Purpose: This study was aimed to evaluate the effect of rhPMP-2 coated implants on alveolar ridge augmentation in dogs. Materials and methods: Six Beagle dogs were used in this study. Six 8.0 mm long anodized surface titanium implants were placed 5 mm into the mandibular alveolar ridge following 6 month of healing period after extraction. Each animal received three implants coated with rhBMP-2 and three uncoated control implants using the randomized split-mouth design. Radiographic examinations were undertaken immediately at implant placement (baseline), at weeks 4 and 8 after implant placement. The amount of bone augmentation was evaluated by measuring the distance from the uppermost point of the coverscrew to the marginal bone. Implant Stability Quotient (ISQ) values were measured immediately at implant placement and 8 weeks after implant placement. For the statistical analysis, Man-Whitney ranksum test and Wilcoxon signed rank test of SPSS 12.0 software were used (P=.05). Results: The BMP group exhibited radiographic vertical bone augmentation about $0.6{\pm}0.7$ mm at 8 weeks later while controls showed bone loss about $0.4{\pm}0.6$ mm. There was significant difference among the rhBMP-2 group and controls in bone level change (P<.05). The ISQ values were significantly higher in the BMP-2 group than the control group at 8 weeks later (P<.05), while there was no significant difference at surgery. Conclusion: Within the limitation of this study, the rhBMP-2 coated on anodized implant could stimulate vertical alveolar bone augmentation, which may increase implant stability significantly on completely healed alveolar ridge.
Keywords
rhBMP-2; implant; Osseointegration; Implant stability; Bone augmentation;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Wikesjo UM, Xiropaidis AV, Qahash M, Lim WH, Sorensen RG, Rohrer MD, Wozney JM, Hall J. Bone formation at recombinant human bone morphogenetic protein-2-coated titanium implants in the posterior mandible (Type II bone) in dogs. J Clin Periodontol 2008;35:985-91.   DOI   ScienceOn
2 Hoar JE, Beck GH, Crawford EA, Resnik R. Prospective evaluation of crestal bone remodeling of a bone-density based dental implant system. Compend Contin Educ Dent 1998;19:17-24.
3 Hall J, Sorensen RG, Wozney JM, Wikesjo UM. Bone formation at rhBMP-2-coated titanium implants in the rat ectopic model. J Clin Periodontol 2007;34:444-51.   DOI   ScienceOn
4 Bostrom MP, Asnis P. Transforming growth factor beta in fracture repair. Clin Orthop Relat Res 1998;(355 Suppl):S124-31.
5 Reddi AH. Bone and cartilage differentiation. Curr Opin Genet Dev 1994;4:737-44.   DOI   ScienceOn
6 Esposito M, Hirsch JM, Lekholm U, Thomsen P. Biological factors contributing to failures of osseointegrated oral implants. (II). Etiopathogenesis. Eur J Oral Sci 1998;106:721-64.   DOI   ScienceOn
7 Simion M, Trisi P, Piattelli A. Vertical ridge augmentation using a membrane technique associated with osseointegrated implants. Int J Periodontics Restorative Dent 1994;14:496-511.
8 Barnes GL, Kostenuik PJ, Gerstenfeld LC, Einhorn TA. Growth factor regulation of fracture repair. J Bone Miner Res 1999;14:1805-15.   DOI   ScienceOn
9 Bessa PC, Casal M, Reis RL. Bone morphogenetic proteins in tissue engineering: the road from the laboratory to the clinic, part I (basic concepts). J Tissue Eng Regen Med 2008;2:1-13.   DOI   ScienceOn
10 Urist MR. Bone: formation by autoinduction. Science 1965;150:893-9.   DOI   ScienceOn
11 Chen D, Zhao M, Mundy GR. Bone morphogenetic proteins. Growth Factors 2004;22:233-41.   DOI   ScienceOn
12 Bessho K, Konishi Y, Kaihara S, Fujimura K, Okubo Y, Iizuka T. Bone induction by Escherichia coli - derived recombinant human bone morphogenetic protein-2 compared with Chinese hamster ovary cell-derived recombinant human bone morphogenetic protein-2. Br J Oral Maxillofac Surg 2000;38:645-9.   DOI   ScienceOn
13 Reddi AH. Role of morphogenetic proteins in skeletal tissue engineering and regeneration. Nat Biotechnol 1998;16:247-52.   DOI   ScienceOn
14 Leknes KN, Yang J, Qahash M, Polimeni G, Susin C, Wikesjo UM. Alveolar ridge augmentation using implants coated with recombinant human bone morphogenetic protein-2: radiographic observations. Clin Oral Implants Res 2008;19:1027-33.   DOI   ScienceOn
15 Bessa PC, Casal M, Reis RL. Bone morphogenetic proteins in tissue engineering: the road from laboratory to clinic, part II (BMP delivery). J Tissue Eng Regen Med 2008;2:81-96.   DOI   ScienceOn